Fingerprint
Dive into the research topics of 'A phase I/II study of the combination of quizartinib with azacitidine or low-dose cytarabine for the treatment of patients with acute myeloid leukemia or myelodysplastic syndrome'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically